Spain is a well-developed pharmaceutical market due to the availability of numerous innovative therapies covered under the country’s universal healthcare policy. Unique to Spain is the role of the 17 regional autonomous communities, administrative divisions that sit above the provincial level. Each autonomous community determines its own budget and reimbursement guidelines.
Changes in the promotion of pharmaceutical products in Spain has led to a new self-regulation system the pharmaceutical industry with this new version of the Code of Practice for the Pharmaceutical Industry, approved by the governing bodies of Farmaindustria in December 2013 and ratified by Farmaindustria General Assembly in June 2014.
Sign up to get the guides
Select the guides you wish to download